"Anti-woke" multimillionaire Vivek Ramaswamy launches longshot GOP White House bid
Vivek Ramaswamy, a wealthy former biotech executive, jumped into the Republican presidential race Tuesday night, announcing his candidacy in a video released on Twitter and with an appearance on Fox News.
The 37-year-old Ramaswamy is running his longshot campaign as an "anti-woke" capitalist who opposes what he considers liberal "woke" indoctrination in corporate investment based on E.S.G., or environmental, societal and governance principles. Ramaswamy has written two books, including "Woke, Inc" — a popular text in conservative circles due to its push to bring a culture war to the corporate world.
"We're in the middle of a national identity crisis. Faith, patriotism and hard work have disappeared," Ramaswamy said in his announcement video. "We hunger to be part of something bigger than ourselves. Yet we can't even answer the question of what it means to be an American."
Ramaswamy said that the "woke left" has "created a new culture of fear in our country that has completely replaced our culture of free speech in America."
Ramaswamy had already made trips to early primary states, including Iowa, before he officially filed with the FEC on Tuesday.
The multimillionaire Ohio native has ties to Republican Senator J.D. Vance and billionaire Republican donor Peter Thiel. Ramaswamy, Vance and Thiel started the hedge fund Strive, which encourages investments that stay away from so-called "woke capitalism."
Ramaswamy is the latest Republican to formally announce a bid for the presidency in 2024. Other notable candidates include former President Donald Trump and former South Carolina Governor Nikki Haley, who also served as Trump's U.N. ambassador.
Executive producer: Arden Farhi
Producers: Jamie Benson, Jacob Rosen, Sara Cook and Eleanor Watson
CBSN Production: Eric Soussanin
Show email: TakeoutPodcast@cbsnews.com
Twitter: @TakeoutPodcast
Instagram: @TakeoutPodcast
Facebook: Facebook.com/TakeoutPodcast
Fin Gómez is CBS News' political director.
TwitterDisclaimer: The copyright of this article belongs to the original author. Reposting this article is solely for the purpose of information dissemination and does not constitute any investment advice. If there is any infringement, please contact us immediately. We will make corrections or deletions as necessary. Thank you.
